ArticleScientific reports2024

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Giovanni Brandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.